Brendan D Curti1, Mark B Faries1. Show Affiliations » 1. From the Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR (B.D.C.); and Cedars-Sinai Medical Center and the Angeles Clinic and Research Institute, Los Angeles (M.B.F.).
Abstract
Entities: Disease
Mesh: See more » Antineoplastic Agents/therapeutic useCancer VaccinesHumansImmune Checkpoint Inhibitors/therapeutic useMargins of ExcisionMelanoma/drug therapyMelanoma/mortalityMelanoma/surgeryNeoadjuvant TherapySkin Neoplasms/drug therapySkin Neoplasms/mortalitySkin Neoplasms/surgery
Substances: See more » Antineoplastic AgentsCancer VaccinesImmune Checkpoint Inhibitors
Year: 2021 PMID: 34107182 DOI: 10.1056/NEJMra2034861
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245